The Limitations of Traditional Antibody Discovery and AI’s Disruptive Potential For decades, antibody drug development has relied on labor-intensive methods such as hybridoma technology and phage display—processes that often requiring 10-15 yearsRead More…

Introduction: The Convergence of AI and Medicine In recent years, the intersection of artificial intelligence (AI) and healthcare has emerged as one of the most promising frontiers. Among the myriad applications, theRead More…